MedTrace Logo

Chlorhexidine Disk for Prevention of Exit-site Infection in Peritoneal Dialysis Patients

NCT03406520 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2020-03-23

No results posted yet for this study

Summary

The purpose of the study is to evaluate the efficacy and safety of chlorhexidine-impregnated disk in preventing catheter exit-site infection in peritoneal dialysis patients

Conditions

  • Peritoneal Dialysis Catheter Exit Site Infection

Interventions

DEVICE

Chlorhexidine-impregnated disk

The chlorhexidine-impregnated sponge, named biopatch, is a protective disk (2.5 cm x 0.7 cm), which is hydrophilic polyurethane absorptive foam with chlorhexidine gluconate, in average of 86.8mg per disk

Sponsors & Collaborators

Principal Investigators

  • Htay Htay · Singapore General Hospital

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-07
Primary Completion
2019-10-01
Completion
2019-10-25
FDA Device
Yes

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03406520 on ClinicalTrials.gov